Your browser is no longer supported. Please, upgrade your browser.
HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite Help
publish chart | save to portfolio | create alert Type: candle | line | advanced | interactive | perf    Timeframe: intraday | daily | weekly | monthly
NBY NovaBay Pharmaceuticals, Inc. daily Stock Chart
NBY [NYSE]
NovaBay Pharmaceuticals, Inc.
Healthcare | Biotechnology | USA
statements
Index- P/E- EPS (ttm)-0.47 Insider Own25.54% Shs Outstand26.04M Perf Week16.59%
Market Cap15.43M Forward P/E- EPS next Y-0.23 Insider Trans0.00% Shs Float16.25M Perf Month-9.35%
Income-8.20M PEG- EPS next Q-0.07 Inst Own7.70% Short Float2.00% Perf Quarter5.80%
Sales8.50M P/S1.82 EPS this Y-215.40% Inst Trans-52.58% Short Ratio1.11 Perf Half Y-10.23%
Book/sh0.13 P/B4.56 EPS next Y45.20% ROA-75.70% Target Price1.43 Perf Year-55.78%
Cash/sh0.35 P/C1.71 EPS next 5Y- ROE-308.80% 52W Range0.23 - 4.04 Perf YTD-7.42%
Dividend- P/FCF- EPS past 5Y48.30% ROI-157.50% 52W High-85.33% Beta5.18
Dividend %- Quick Ratio1.90 Sales past 5Y29.20% Gross Margin81.40% 52W Low158.73% ATR0.04
Employees70 Current Ratio2.00 Sales Q/Q-48.40% Oper. Margin- RSI (14)53.75 Volatility8.05% 7.11%
OptionableNo Debt/Eq1.03 EPS Q/Q86.40% Profit Margin-96.70% Rel Volume1.09 Prev Close0.60
ShortableYes LT Debt/Eq0.00 EarningsMar 26 AMC Payout- Avg Volume292.79K Price0.59
Recom1.50 SMA203.19% SMA50-0.94% SMA200-24.54% Volume320,455 Change-1.07%
Sep-18-19Initiated Ladenburg Thalmann Buy $1.10
Jul-06-18Reiterated H.C. Wainwright Buy $4
Nov-15-17Reiterated Laidlaw Buy $10 → $8
Jun-05-17Initiated ROTH Capital Buy $5.50
Mar-27-17Initiated Laidlaw Buy $10
Feb-06-17Initiated Rodman & Renshaw Buy $6
Mar-07-16Downgrade Maxim Group Buy → Hold
Dec-14-15Reiterated Maxim Group Buy $1 → $0.23
Apr-30-15Resumed Maxim Group Buy $2
Mar-06-13Initiated Ascendiant Capital Markets Strong Buy $2.25
Jan-03-08Initiated Dawson James Speculative Buy $8
Dec-02-19 06:50AM  NovaBay Pharmaceuticals Launches NovaWipes Eyelid Wipes on Amazon.com Business Wire +5.09%
Nov-18-19 06:50AM  NovaBay Pharmaceuticals Launches NovaSight Daily Vitamin for Ocular Health on Amazon.com Business Wire +29.78%
Nov-07-19 04:05PM  NovaBay Pharmaceuticals Reports 2019 Third Quarter Financial Results Business Wire +9.42%
Nov-04-19 06:50AM  NovaBay Pharmaceuticals Launches Online Sales of CelleRx® Skin Cleanser for Post-Aesthetic Dermatology and Cosmetic Surgery Procedures Business Wire +25.54%
Oct-31-19 06:50AM  NovaBay Pharmaceuticals to Hold Third Quarter 2019 Conference Call on November 7, 2019 Business Wire
Oct-28-19 06:50AM  NovaBay Pharmaceuticals to Distribute the NuLids System® for the Treatment of Dry Eye in Certain U.S. Geographies Business Wire
Sep-24-19 02:20PM  Market Morning: Prorogation Ruled Rogue, High Demand for Fed Repo, New Breast Cancer Tests Market Exclusive
06:50AM  NovaBay Pharmaceuticals Receives Approval for Distribution of Avenova in Australia Business Wire
Sep-16-19 06:50AM  NovaBay Pharmaceuticals Names Finance Executive Jeff Zheng to its Board of Directors Business Wire
Aug-09-19 09:26AM  NovaBay Pharmaceuticals Announces Pricing of $2.7 Million Private Placement of Preferred Stock and Accompanying Warrants to Purchase Common Stock GlobeNewswire -17.29%
09:22AM  NovaBay Pharmaceuticals Announces Pricing of $4.2 Million Registered Direct Offering GlobeNewswire
Aug-07-19 06:50AM  NovaBay Pharmaceuticals Reports 2019 Second Quarter Financial Results Business Wire -6.78%
Jul-29-19 06:50AM  NovaBay Pharmaceuticals Reports 2019 Second Quarter Net Sales of $1.8 Million Business Wire +34.31%
Jul-15-19 06:50AM  NovaBay Pharmaceuticals Issues Letter to Stockholders Business Wire
Jul-01-19 10:17AM  NovaBay Trades Higher After Compliance Plan Accepted By NYSE Benzinga
06:50AM  NovaBay Pharmaceuticals Plan of Compliance Accepted by NYSE Business Wire
Jun-26-19 04:05PM  NovaBay Pharmaceuticals Raises $2.4 Million in a Private Placement Business Wire
Jun-17-19 06:50AM  NovaBay Pharmaceuticals Appoints Justin Hall President and CEO, and Jason Raleigh CFO Business Wire +5.42%
Jun-10-19 01:52PM  NovaBay's stock halted for volatility 18 times as it rockets 557% MarketWatch +874.84%
07:55AM  NovaBay's stock more than triples after Avenova made available on Amazon without prescription MarketWatch
06:50AM  NovaBay Pharmaceuticals Launches Avenova® Direct on Amazon.com Business Wire
May-21-19 04:05PM  NovaBay Pharmaceuticals Receives NYSE American Communication Business Wire
May-09-19 04:05PM  NovaBay Pharmaceuticals Reports First Quarter 2019 Financial Results Business Wire -33.65%
Apr-30-19 06:50AM  NovaBay Pharmaceuticals to Hold First Quarter 2019 Conference Call on May 9, 2019 Business Wire
Apr-17-19 06:50AM  NovaBay Pharmaceuticals Announces Annual Meeting of Stockholders and Receives NYSE American Communication Business Wire -9.26%
Apr-15-19 06:50AM  NovaBay Pharmaceuticals Announces New Partner Pharmacy Program Business Wire +9.46%
Mar-28-19 04:05PM  NovaBay Pharmaceuticals Reports 2018 Fourth Quarter and Full Year Financial Results Business Wire
02:30PM  NovaBay Pharmaceuticals, Inc. to Host Earnings Call ACCESSWIRE
Mar-12-19 04:05PM  NovaBay Pharmaceuticals Announces Strategic Shift in U.S. Avenova Commercialization Strategy Business Wire +7.91%
10:30AM  Analysts Estimate NovaBay Pharmaceuticals (NBY) to Report a Decline in Earnings: What to Look Out for Zacks
Jan-07-19 06:50AM  NovaBay Pharmaceuticals Announces Preliminary 2018 Net Sales and Introduces 2019 Net Sales Guidance Business Wire
Nov-14-18 04:05PM  NovaBay Pharmaceuticals Reports Third Quarter 2018 Financial Results Business Wire
Nov-07-18 06:50AM  NovaBay Pharmaceuticals to Hold Third Quarter 2018 Conference Call on November 14, 2018 Business Wire
Nov-06-18 10:30AM  Will NovaBay Pharmaceuticals (NBY) Report Negative Earnings Next Week? What You Should Know Zacks
Sep-28-18 06:50AM  NovaBay Pharmaceuticals Names Jack McGovern Interim CEO Business Wire
Aug-30-18 08:00AM  NovaBay Pharmaceuticals to Present at H.C. Wainwright 20th Annual Global Investment Conference on September 6 Business Wire +8.82%
Aug-07-18 04:05PM  NovaBay Pharmaceuticals Reports Second Quarter 2018 Financial Results Business Wire
02:30PM  NovaBay Pharmaceuticals, Inc. to Host Earnings Call ACCESSWIRE
Jul-31-18 06:50AM  NovaBay Pharmaceuticals to Hold Second Quarter 2018 Conference Call on August 7, 2018 Business Wire +8.89%
Jul-05-18 06:50AM  NovaBay Pharmaceuticals Expands Sales Organization to Re-energize Growth Business Wire
May-10-18 04:05PM  NovaBay Pharmaceuticals Reports First Quarter 2018 Financial Results Business Wire
May-07-18 06:50AM  NovaBay Pharmaceuticals to Hold First Quarter 2018 Conference Call on May 10, 2018 Business Wire
Mar-20-18 04:05PM  NovaBay Pharmaceuticals Reports 2017 Fourth Quarter and Full Year Financial Results Business Wire
12:00PM  NovaBay Pharmaceuticals, Inc. to Host Earnings Call ACCESSWIRE
07:41AM  NovaBay Pharmaceuticals Q4 Earnings Outlook Benzinga
Mar-01-18 10:49PM  BRIEF-Jinzi Ham's Unit Scraps Plan To Invest In Novabay Pharma, To Boost Asset Management Subsidiary's Capital Reuters
03:53AM  BRIEF-Jinzi Ham's Unit Scraps Plan To Invest In Novabay Pharma, To Boost Asset Management Subsidiary's Capital Reuters
Feb-21-18 06:50AM  NovaBay Pharmaceuticals to Hold 2017 Fourth Quarter and Full Year Conference Call on March 20, 2018 Business Wire
Feb-12-18 06:50AM  NovaBay Pharmaceuticals Completes $6.0 Million Private Placement Business Wire
Jan-08-18 06:50AM  NovaBay Pharmaceuticals Announces Preliminary Sales for 2017 Fourth Quarter and Full Year Business Wire
Dec-22-17 06:50AM  NovaBay Pharmaceuticals Receives Stockholder Approval for Proposed $10.32 Million Financing Agreement Business Wire
Dec-21-17 06:50AM  NovaBay Pharmaceuticals Regains Compliance with NYSE American Continued Listing Standards Business Wire
Dec-19-17 01:41PM  ETFs with exposure to NovaBay Pharmaceuticals, Inc. : December 19, 2017 Capital Cube
Dec-06-17 06:50AM  NovaBay Pharmaceuticals Names Lewis J. Stuart Chief Commercial Officer Business Wire
Nov-30-17 02:09PM  ETFs with exposure to NovaBay Pharmaceuticals, Inc. : November 30, 2017 Capital Cube
Nov-29-17 08:02AM  NovaBay Pharmaceuticals, Inc. :NBY-US: Earnings Analysis: Q3, 2017 By the Numbers : November 29, 2017 Capital Cube
Nov-14-17 04:05PM  NovaBay Pharmaceuticals Reports Third Quarter 2017 Financial Results Business Wire
11:00AM  NovaBay Pharmaceuticals, Inc. to Host Earnings Call ACCESSWIRE
05:01AM  BRIEF-Jinzi Ham's unit to invest in Novabay Pharma and become its biggest shareholder Reuters
Nov-07-17 06:50AM  NovaBay Pharmaceuticals to Hold Third Quarter 2017 Conference Call on November 14 Business Wire
Sep-26-17 09:00AM  Dry Eye Advances from NovaBay and Johnson & Johnson Vision's TearScience ACCESSWIRE
Sep-20-17 06:50AM  NovaBay Pharmaceuticals Receives Notification of Noncompliance with Additional NYSE American Continued Listing Standards Business Wire
Sep-19-17 06:10PM  ETFs with exposure to NovaBay Pharmaceuticals, Inc. : September 19, 2017 Capital Cube
Sep-18-17 12:01PM  NovaBay Pharmaceuticals, Inc. :NBY-US: Earnings Analysis: Q2, 2017 By the Numbers : September 18, 2017 Capital Cube
09:00AM  Eye Surgeon Says Keep Eyelids Healthy with Avenova from NovaBay ACCESSWIRE
Sep-05-17 06:50AM  NovaBay Pharmaceuticals to Present at Rodman & Renshaw 19th Annual Global Investment Conference Business Wire
Aug-14-17 09:00AM  NovaBay's Avenova Offers Key Benefits in Glaucoma Care ACCESSWIRE
Aug-10-17 04:05PM  NovaBay Pharmaceuticals Reports Second Quarter 2017 Financial Results Business Wire
02:00PM  Investor Network: NovaBay Pharmaceuticals, Inc. to Host Earnings Call ACCESSWIRE
Aug-03-17 06:50AM  NovaBay Pharmaceuticals to Hold 2017 Second Quarter Conference Call on August 10, 2017 Business Wire
Jul-24-17 10:00AM  Fighting Parasitic Eyelid Mites with Avenova from NovaBay Pharmaceuticals Accesswire
Jul-10-17 01:32PM  UPDATE: NovaBay's Avenova Highlighted in National Dry Eye Awareness Month Accesswire
10:00AM  NovaBay's Avenova Highlighted in National Dry Eye Awareness Month Accesswire
06:50AM  NovaBay Pharmaceuticals Announces CFO Transition Business Wire
Jun-26-17 06:50AM  NovaBay Pharmaceuticals Joins the Russell Microcap Index Business Wire
Jun-13-17 10:14AM  NovaBay Pharmaceuticals, Inc. :NBY-US: Earnings Analysis: Q1, 2017 By the Numbers : June 13, 2017 Capital Cube
May-30-17 06:50AM  NovaBay Pharmaceuticals to Present at the 7th Annual LD Micro Invitational Business Wire
May-19-17 04:05PM  NovaBay Pharmaceuticals Receives Noncompliance Notice from NYSE MKT Business Wire
May-11-17 04:05PM  NovaBay Pharmaceuticals Reports First Quarter 2017 Financial Results Business Wire
May-04-17 06:50AM  NovaBay Pharmaceuticals to Hold 2017 First Quarter Conference Call on May 11, 2017 Business Wire
May-02-17 10:00AM  Avenova from NovaBay Pharmaceuticals is Effective for Managing Dry Eye before Refractive and Cataract Eye Surgery Accesswire
Apr-17-17 10:00AM  NovaBay's intelli-Case Can Safely and Effectively Disinfect Contact Lenses, CEOCFO Magazine Reports Accesswire
Mar-29-17 01:04PM  NOVABAY PHARMACEUTICALS, INC. Financials
Mar-28-17 12:47PM  NovaBay Pharmaceuticals, Inc. :NBY-US: Earnings Analysis: Q4, 2016 By the Numbers : March 28, 2017 Capital Cube
12:47PM  NovaBay Pharmaceuticals, Inc. :NBY-US: Earnings Analysis: Q4, 2016 By the Numbers : March 28, 2017
10:33AM  NovaBay Pharmaceuticals, Inc. :NBY-US: Earnings Analysis: 2016 By the Numbers : March 28, 2017
10:00AM  Avenova from NovaBay Pharmaceuticals Effective for Painful Eye Condition Accesswire
Mar-27-17 08:57AM  Coverage initiated on NovaBay Pharma by Laidlaw
Mar-24-17 10:50AM  Edited Transcript of NBY earnings conference call or presentation 23-Mar-17 8:30pm GMT Thomson Reuters StreetEvents
Mar-23-17 04:14PM  NOVABAY PHARMACEUTICALS, INC. Files SEC form 10-K, Annual Report
04:05PM  NovaBay Pharmaceuticals Reports 2016 Full Year and Fourth Quarter Financial Results and Provides 2017 Financial Guidance Business Wire
07:07AM  Q4 2016 NovaBay Pharmaceuticals Inc Earnings Release - After Market Close
Mar-16-17 06:50AM  NovaBay Pharmaceuticals to Hold 2016 Fourth Quarter and Full Year Conference Call on March 23, 2017 Business Wire
Mar-09-17 06:50AM  NovaBay Pharmaceuticals to Present Features and Benefits of the intelli-Case at FDA Public Advisory Meeting Business Wire
Mar-08-17 10:00AM  Explaining Innovative Drug Technologies Through Animation Accesswire
Mar-07-17 06:50AM  NovaBay Pharmaceuticals to Present at 29th Annual ROTH Conference Business Wire
Feb-14-17 10:00AM  Relief from Painful Dry Eye Can be a Real Valentine's Day Gift Accesswire
Jan-30-17 10:00AM  NovaBay CEO Sees Continued Double-Digit Revenue Growth in 2017 Accesswire
Jan-27-17 10:00AM  NovaBay Pharmaceuticals' "Avenova" Helping Patients with Contact Lens Intolerance Accesswire
Jan-09-17 06:50AM  NovaBay Pharmaceuticals Announces Preliminary Sales for the Fourth Quarter of 2016 Business Wire
NovaBay Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets non-antibiotic anti-infective products for the eye care market in the United States, China, and internationally. It offers Avenova, a prescription product for cleansing and removing foreign materials, including microorganisms and debris from skin around the eye; NeutroPhase for wound care market; CelleRx for the aesthetic dermatology market; Aganocide compounds patented synthetic molecules for use against bacteria, viruses, and fungi; auriclosene irrigation solution for urology; and intelli-Case, a device for soft and rigid gas permeable contact lenses. NovaBay Pharmaceuticals, Inc. has collaboration and license agreement with Virbac to develop auriclosene, a proprietary compound for veterinary markets. The company was formerly known as NovaCal Pharmaceuticals, Inc. and changed its name to NovaBay Pharmaceuticals, Inc. in February 2007. NovaBay Pharmaceuticals, Inc. was incorporated in 2000 and is based in Emeryville, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
WU MIJIADirectorJun 11Sale4.0415,87364,1270Jun 13 06:03 AM
Fu Jian Ping10% OwnerJun 11Sale3.84380,9541,462,8635,302,350Jun 13 09:46 PM
Pioneer Pharma (Hong Kong) Co 10% OwnerJun 11Sale4.0424,32698,2775,188,421Jun 13 09:32 PM
WU MIJIADirectorJun 10Sale2.0347,61996,6670Jun 13 06:03 AM
open in yahoo | open in reuters | open in google